Cat# : HIV-291
| Catalog# | Product Name | Availability | Size | Price | Qty |
|---|---|---|---|---|---|
| HIV-291 | Recombinant Trimeric S Subunit Vaccine | April 27, 2024 | 1 vial | $998.00 |
|
| Add to Cart Online Order Request a Bulk Order | |||||
| Cat#: | HIV-291 |
| Product Name: | Recombinant Trimeric S Subunit Vaccine |
| Description: | SCB-2019 is a recombinant trimeric S protein subunit vaccine candidate being investigated against COVID-19. This vaccine candidate resembles the native trimeric viral spike and is produced through mammalian cell-culture. The vaccine was developed and tested by Clover Biopharmaceuticals AUS Pty Ltd.. As of June 2020, the company is pursuing a randomized, double blind, placebo controlled study (NCT04405908) to test the safety and immunogenicity of the vaccine. |
| Biologic Classification: | Vaccines Recombinant |
For more information on how our products could help advance your project, please contact us.
ENTER YOUR EMAIL HERE TO SUBSCRIBE.
Copyright © 2024 Creative BioMart. All Rights Reserved.
